836 related articles for article (PubMed ID: 33845483)
21. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
22. Cellular host factors for SARS-CoV-2 infection.
Baggen J; Vanstreels E; Jansen S; Daelemans D
Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
[TBL] [Abstract][Full Text] [Related]
23. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
Selkrig J; Stanifer M; Mateus A; Mitosch K; Barrio-Hernandez I; Rettel M; Kim H; Voogdt CGP; Walch P; Kee C; Kurzawa N; Stein F; Potel C; Jarzab A; Kuster B; Bartenschlager R; Boulant S; Beltrao P; Typas A; Savitski MM
Mol Syst Biol; 2021 Feb; 17(2):e10188. PubMed ID: 33590968
[TBL] [Abstract][Full Text] [Related]
26. Progress in understanding COVID-19: insights from the omics approach.
Lin B; Liu J; Liu Y; Qin X
Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
[TBL] [Abstract][Full Text] [Related]
27. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
van de Leemput J; Han Z
Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
[TBL] [Abstract][Full Text] [Related]
29. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication.
Zhang L; Zhang ZP; Zhang XE; Lin FS; Ge F
J Virol; 2010 Jun; 84(12):6050-9. PubMed ID: 20392858
[TBL] [Abstract][Full Text] [Related]
30. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
Gordon DE; Hiatt J; Bouhaddou M; Rezelj VV; Ulferts S; Braberg H; Jureka AS; Obernier K; Guo JZ; Batra J; Kaake RM; Weckstein AR; Owens TW; Gupta M; Pourmal S; Titus EW; Cakir M; Soucheray M; McGregor M; Cakir Z; Jang G; O'Meara MJ; Tummino TA; Zhang Z; Foussard H; Rojc A; Zhou Y; Kuchenov D; Hüttenhain R; Xu J; Eckhardt M; Swaney DL; Fabius JM; Ummadi M; Tutuncuoglu B; Rathore U; Modak M; Haas P; Haas KM; Naing ZZC; Pulido EH; Shi Y; Barrio-Hernandez I; Memon D; Petsalaki E; Dunham A; Marrero MC; Burke D; Koh C; Vallet T; Silvas JA; Azumaya CM; Billesbølle C; Brilot AF; Campbell MG; Diallo A; Dickinson MS; Diwanji D; Herrera N; Hoppe N; Kratochvil HT; Liu Y; Merz GE; Moritz M; Nguyen HC; Nowotny C; Puchades C; Rizo AN; Schulze-Gahmen U; Smith AM; Sun M; Young ID; Zhao J; Asarnow D; Biel J; Bowen A; Braxton JR; Chen J; Chio CM; Chio US; Deshpande I; Doan L; Faust B; Flores S; Jin M; Kim K; Lam VL; Li F; Li J; Li YL; Li Y; Liu X; Lo M; Lopez KE; Melo AA; Moss FR; Nguyen P; Paulino J; Pawar KI; Peters JK; Pospiech TH; Safari M; Sangwan S; Schaefer K; Thomas PV; Thwin AC; Trenker R; Tse E; Tsui TKM; Wang F; Whitis N; Yu Z; Zhang K; Zhang Y; Zhou F; Saltzberg D; ; Hodder AJ; Shun-Shion AS; Williams DM; White KM; Rosales R; Kehrer T; Miorin L; Moreno E; Patel AH; Rihn S; Khalid MM; Vallejo-Gracia A; Fozouni P; Simoneau CR; Roth TL; Wu D; Karim MA; Ghoussaini M; Dunham I; Berardi F; Weigang S; Chazal M; Park J; Logue J; McGrath M; Weston S; Haupt R; Hastie CJ; Elliott M; Brown F; Burness KA; Reid E; Dorward M; Johnson C; Wilkinson SG; Geyer A; Giesel DM; Baillie C; Raggett S; Leech H; Toth R; Goodman N; Keough KC; Lind AL; ; Klesh RJ; Hemphill KR; Carlson-Stevermer J; Oki J; Holden K; Maures T; Pollard KS; Sali A; Agard DA; Cheng Y; Fraser JS; Frost A; Jura N; Kortemme T; Manglik A; Southworth DR; Stroud RM; Alessi DR; Davies P; Frieman MB; Ideker T; Abate C; Jouvenet N; Kochs G; Shoichet B; Ott M; Palmarini M; Shokat KM; García-Sastre A; Rassen JA; Grosse R; Rosenberg OS; Verba KA; Basler CF; Vignuzzi M; Peden AA; Beltrao P; Krogan NJ
Science; 2020 Dec; 370(6521):. PubMed ID: 33060197
[TBL] [Abstract][Full Text] [Related]
31. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
32. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
Suhail S; Zajac J; Fossum C; Lowater H; McCracken C; Severson N; Laatsch B; Narkiewicz-Jodko A; Johnson B; Liebau J; Bhattacharyya S; Hati S
Protein J; 2020 Dec; 39(6):644-656. PubMed ID: 33106987
[TBL] [Abstract][Full Text] [Related]
33. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
Akaji K; Konno H
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
[TBL] [Abstract][Full Text] [Related]
34. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
Venkataraman T; Coleman CM; Frieman MB
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
[TBL] [Abstract][Full Text] [Related]
35. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.
Pfefferle S; Schöpf J; Kögl M; Friedel CC; Müller MA; Carbajo-Lozoya J; Stellberger T; von Dall'Armi E; Herzog P; Kallies S; Niemeyer D; Ditt V; Kuri T; Züst R; Pumpor K; Hilgenfeld R; Schwarz F; Zimmer R; Steffen I; Weber F; Thiel V; Herrler G; Thiel HJ; Schwegmann-Wessels C; Pöhlmann S; Haas J; Drosten C; von Brunn A
PLoS Pathog; 2011 Oct; 7(10):e1002331. PubMed ID: 22046132
[TBL] [Abstract][Full Text] [Related]
36. Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses.
Shi R; Feng Z; Zhang X
Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):707-726. PubMed ID: 34774773
[TBL] [Abstract][Full Text] [Related]
37. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors.
Cao Y; Yang R; Lee I; Zhang W; Sun J; Wang W; Meng X
Protein Sci; 2021 Jun; 30(6):1114-1130. PubMed ID: 33813796
[TBL] [Abstract][Full Text] [Related]
39. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
Kamel W; Noerenberg M; Cerikan B; Chen H; Järvelin AI; Kammoun M; Lee JY; Shuai N; Garcia-Moreno M; Andrejeva A; Deery MJ; Johnson N; Neufeldt CJ; Cortese M; Knight ML; Lilley KS; Martinez J; Davis I; Bartenschlager R; Mohammed S; Castello A
Mol Cell; 2021 Jul; 81(13):2851-2867.e7. PubMed ID: 34118193
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic profiling of COVID-19 and SARS-like viruses.
Nain Z; Rana HK; Liò P; Islam SMS; Summers MA; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1175-1196. PubMed ID: 32778874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
